News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Clinical trials
Testing HIV Prevention Tools: Other Ways Up the Alley

We need to design prevention trials that ask, “Is this test product better than nothing?” rather than, “Is this test product better than the best available prevention combination we have?”

Published
15 March 2013
From
Poz
History of HIV and AIDS
The Battle for Needle Exchange, as AIDS Raged

In the '80s, HIV was killing tens of thousands of heroin addicts. Yet swapping clean needles for dirty ones remained illegal—until a ragtag group of AIDS activists put their bodies on the line.

Published
14 March 2013
From
The Fix
Lipodystrophy
Health Canada rejects tesamorelin for lipodystrophy

After consideration of the NDS, Health Canada decided that the risks of tesamorelin outweighed its benefits under the proposed conditions of use.

Published
13 March 2013
From
Theratechnologies press release
UK health services
NHS in London spends £13m on PR

The NHS in London spent almost £13m on public relations in the last three years, a BBC London investigation finds. Some trusts said PR spending was needed to educate the public on health issues. Yet the outlay on staff press officers was supplemented by millions of pounds handed to private PR firms.

Published
13 March 2013
From
BBC Health
Injecting drug use
HIV high on the agenda at the fifty-sixth session of the Commission on Narcotic Drugs

At the fifty-sixth session of the Commission on Narcotic Drugs, which is running from 11-15 March, drug use and HIV will be addressed through a number of channels, including a draft resolution calling for the intensification of efforts to reduce HIV to attain the targets of the 2011 Political Declaration on HIV and AIDS.

Published
13 March 2013
From
UNAIDS
PrEP
Preventing HIV Infection With Anti-HIV Drugs in People at Risk Is Cost-Effective

An HIV prevention strategy in which people at risk of becoming exposed to HIV take antiretroviral drugs to reduce their chance of becoming infected (often referred to as pre-exposure prophylaxis or PrEP), may be a cost-effective method

Published
13 March 2013
From
Science Daily
Drug-resistant TB
An Activist’s Guide to Bedaquiline (Sirturo)

Bedaquiline (also known by its trade name, Sirturo, or as TMC207) is the first new drug from a new drug class to treat TB to be approved by the United States Food and Drug Administration (FDA) in over 40 years. This guide highlights important safety and efficacy data reported thus far and offers advocacy recommendations for activists to take forward. .

Published
12 March 2013
From
Treatment Action Group
Access to medicines and treatment
Third-line ARVs could widen treatment gap in Zimbabwe

HIV/AIDS activists in Zimbabwe have welcomed the government's move to address the problem of HIV drug resistance by introducing third-line antiretroviral drug (ARVs). But it remains unclear how the cash-strapped government will finance this, as procuring the drugs will invariably be expensive and could divert resources away from other HIV treatment efforts.

Published
12 March 2013
From
IRIN Plus News
Prevention of mother-to-child transmission
Malawi achieves seven-fold increase in ART for pregnant and breastfeeding women

Eighteen months after implementation of 'Option B+' in Malawi – ART for life for all HIV-infected, pregnant or breastfeeding women regardless of CD4 count or disease

Published
12 March 2013
By
Carole Leach-Lemens
HIV prevention policy
Craig Timberg and Daniel Halperin: Five myths about AIDS

1. The case of the Mississippi baby means we’re close to curing AIDS. 2. AIDS is the leading killer of babies worldwide. 3. Mothers with HIV should never breast-feed. 4. Drugs are the key to preventing HIV’s spread. 5. AIDS can’t be defeated.

Published
12 March 2013
From
Washington Post
← Prev12345...330Next →

Filter by country